Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

In a recent study, multiple reproductive health factors were linked to breast cancer incidence among women in the Caribbean.

Association between breast cancer and reproductive health noted

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

Prenatal SSRI or SNRI discontinuation not linked to adverse psychiatric outcomes

In a recent study, postmenopausal women in lower Tertiles of Estradiol concentration experienced an increased prevalence of abdominal aortic calcification.

Lower estradiol linked to abdominal aortic calcification risk

In a recent study, approximately half of infective endocarditis cases were women who inject drugs, despite only one-third of people who inject drugs being women.

High infective endocarditis rates found among women who inject drugs

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

LinkedIn

RSS Feed

Spotlight

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Authors

Over the past two decades, an epidemic of multiple pregnancies has taken place in the developed world due to the widespread use of assisted reproductive technology. The general public has come to accept the phenomenon of higher order multiple as being a normal occurrence, expecting a good outcome for both the fetuses and the mother.

Multiple Pregnancy: Epidemiology, Gestation & Perinatal Outcome. Second Edition

Saying "obstetrician-gynecologist" is a mouthful for most people, and it's probably the most abbreviated specialty in medicine, both spoken and written. However, there doesn't seem to be a consensus on how to pronounce OB-GYN. First, is it the two-syllable "O-B" or the monosyllabic "Ob"? Second, is it "gin" or "gyne" (like "Lyme")? I wonder if you have a preference. I know I do.

Almost nobody says "obstetrician-gynecologist" when speaking about these specialist physicians. But what's the "correct" way to pronounce OB/GYN?

Is It Ob-Gin or Ob-Gyne?

A 27-year-old woman presents with an 18-month history of vulvar irritation. She is otherwise healthy except for episodes of depression. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole. She used oral steroids but developed knee pain. Tacrolimus has not helped. A biopsy revealed lichen simplex chronicus. Immunofluorescent studies were negative.

A 27-year-old woman presents with an 18-month history of vulvar irritation. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole without relief. What's your diagnosis?

Vulvar irritation in a 27-year-old woman

While often asymptomatic, uterine fibroids affect 70 to 80% of women in the U.S. by age 50 and can significantly impact their quality of life. AHN Women’s Institute has a highly specialized team that provides patients with options tailored for their condition and individual needs.

The team offers a full array of diagnostic and therapeutic procedures for uterine fibroids and treatment plans based on a patient’s symptoms. AHN’s fibroid specialists include gynecologists, urogynecologists, diagnostic radiologists, interventional radiologists, and nurse practitioners. They work collaboratively to streamline patients’ care, so they receive coordinated, comprehensive treatment.

“Early detection and intervention can considerably improve outcomes and minimize the potential complications associated with uterine fibroids,” said Noah Rindos, MD, an AHN minimally invasive gynecologist. “We encourage women to seek medical attention if they experience any concerning symptoms. Our goal is to deliver the safest, most effective treatments so patients can stay healthy.”

A common condition with diverse presentations

Uterine fibroids are the most common benign tumors in women of childbearing age. These growths run the gamut of presentations. Fibroids grow in and around the muscular wall of the uterus as a single tumor or as several. They can be as small as an apple seed or as big as a grapefruit, and they can grow or stay about the same size over time.

Fibroids can also manifest in a variety of ways, ranging from mild discomfort to severe pain and debilitating symptoms. Common symptoms include heavy menstrual bleeding, pelvic pain, and pressure on the bladder and rectum, which cause frequent urination or constipation. In some cases, fibroids can interfere with conception, impacting a patient’s reproductive goals.

For asymptomatic or minimally symptomatic patients, watching and waiting may be the most appropriate option because fibroids are rarely cancerous. This involves close monitoring and observation, with intervention only if symptoms worsen or become intolerable.

For patients experiencing mild to moderate symptoms, medical management can be effective. This may include hormonal therapy, including oral contraceptives to regulate menstrual cycles and reduce bleeding. Certain types of intrauterine devices (IUD) can also reduce heavy bleeding.

When medical management fails or symptoms are severe, patients may consider interventional procedures.

AHN Women’s Institute offers a range of minimally invasive and noninvasive procedures that result in fewer incisions and help patients recover faster. These approaches ease fibroid symptoms without affecting surrounding healthy tissue.

Uterine fibroid embolization (UFE) is a valuable treatment option for women with symptomatic fibroids who are not candidates for surgery or who prefer a less invasive approach. Doctors insert a catheter through an artery in the groin or wrist and guide it to the arteries supplying the fibroids with blood. The catheter releases small particles that cut off blood supply to the fibroids, so they shrink. This procedure also preserves the uterus.

“UFE has a high success rate in reducing fibroid size and alleviating symptoms. This is a great option for women who want to preserve their fertility and avoid major surgery,” Dr. Rindos said.

If nonsurgical treatments fail to resolve symptoms, the team may recommend surgery, including myomectomy and hysterectomy. AHN surgeons perform both as a minimally invasive procedure or an open surgery, depending on the patient’s case.

Committed to patient education and support

AHN’s comprehensive approach to uterine fibroids ensures patients receive the highest quality care, truly focused on their situation and needs. AHN offers support groups for women with uterine fibroids, providing a safe space to share experiences and connect with others. The team also has convenient scheduling options and multiple locations throughout the region, ensuring patients have easy access to care.

“Our team-based approach provides timely and effective relief,” Dr. Rindos said. “By combining advanced technology, expert physicians, and a commitment to patient education and support, we strive to empower women to manage their fibroids and live healthy, fulfilling lives.”

To refer a patient to AHN Women’s Institute, call 412-DOCTORS.

NOINDEX

NOFOLLOW

AHN Women’s Institute delivers optimal outcomes for patients with uterine fibroids

These are 3D ultrasound images of a 14-week fetus. What is your diagnosis?

occipital meningocele and umbilical hernia

Clinical

DailyDx: 3D Images of a 14-week fetus

In a recent interview ObGyn.net conducted for 

 on comprehensive care and cancer screenings at well-woman visits, the topic of stethoscopes came up. Ilene S. Gewirtz, MD, the interviewee, mentioned that she still carries a stethoscope and listens to her patients' heart and lungs at well-woman visits. She also said that she believes she's in the minority regarding this practice. We want to know if she's right.

POLL: Many women consider their OB/GYN their primary care provider. But like your primary care counterpart, do you carry a stethoscope?

Do OB/GYNs Carry Stethoscopes?

What is your diagnosis based on these images of the ovary?

Challenge your diagnostic skills with this image quiz: Is this ovarian lesion cystic in nature or something else?

Edward J. Hayes

Articles

Latest Updated Articles